... diagnostic RCTs were identified for this guideline. Equality None relevant. ... Studies will be able to include primary, secondary and tertiary care settings ...

... data on these interventions and the fact that none of these interventions are ... at this time. 10.3.8.3. Consideration of clinical benefits ...

... Most people with CFS / ME will improve over time and some people will recover and ... should be reconsidered if none of the following key features are present: post- ...

... Some of the time A little of the time None of the time The fifth and sixth dimensions of the VFQ- ... to the robustness of the conclusions. We were able to use a large ... rupture. This is the first time this data has been deployed in a health- ...

... different during both phases but needed at both times none the less. A theme that frequently arose in ...

... association between recency of aspirin use and ACM. Time Since Last Use None of the studies reported on an association between ... 85 [95% CI, 0.63 to 1.15]). Time Since Last Use None of the studies reported on the association between ...

... changes that may be associated with entering full-time care. None of the key trials reported rates of people ... c3% c 3.5% 3.5% 3.0% none - 1-year analysis only 3.5% 3.0% Time horizon lifetime lifetime 5 years 10 years 10 ...

... a second PET- CT scan and at the time of publication, none had evidence of malignant disease. Fourteen patients developed clinically detectable stage III disease and underwent surveillance PET- CT with a mean follow-up time of 34 months (range: 15-24 months) and ...

... reported EuroQol 5D (EQ-5D) scores at various time points postintervention. None of the studies reported a statistically significant difference ... 152 reported DVT as an outcome at various time points that precluded meta-analysis. None of the studies reported a significant difference between ...